Literature DB >> 20084461

Neuronopathic Gaucher disease: demographic and clinical features of 131 patients enrolled in the International Collaborative Gaucher Group Neurological Outcomes Subregistry.

Anna Tylki-Szymańska1, Ashok Vellodi, Amal El-Beshlawy, J Alexander Cole, Edwin Kolodny.   

Abstract

OBJECTIVE: To describe demographic, genetic, and clinical characteristics of patients with neuronopathic Gaucher disease (NGD).
METHODS: All patients enrolled in the Neurological Outcomes Subregistry of the International Collaborative Gaucher Group (ICGG) Gaucher Registry as of June 2007 were identified.
RESULTS: The study cohort comprised 131 patients from 17 countries who were enrolled in the Neurological Outcomes Subregistry. The onset of neurological manifestations had occurred before 2 years of age in 47% (61 out of 131 patients), 2 years of age or older in 41% (54 out of 131), and could not be ascertained in the remaining 12% (16 out of 131). The most common manifestations were inability to look to the extreme up or down (45%, 55 out of 123), abnormally slow object tracking (43%, 53 out of 123), convergent squint (36%, 44 out of 121), and ataxia (15 to 20%, 18-27 out of 117). Seizures were reported in 19 out of 122 patients (16%), and myoclonic seizures were reported in 3 out of 121 patients (2%). The most common genotypes were L444P/L444P (76 out of 108, 70%), L444P/D409H (9 out of 108, 8%), D409H/D409H (8 out of 108, 7%), and L444P/rare allele (6 out of 108, 6%); full sequencing was not performed in all patients.
CONCLUSIONS: Neurological manifestations of GD often begin to appear before the age of 2 years. The most common neurological signs and manifestations are brainstem abnormalities and fine motor dysfunction. The most common genotype is L444P/L444P.

Entities:  

Mesh:

Year:  2010        PMID: 20084461     DOI: 10.1007/s10545-009-9009-6

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  14 in total

1.  Enzyme replacement therapy in type III Gaucher disease.

Authors:  A Tylki-Szymańska; B Czartoryska
Journal:  J Inherit Metab Dis       Date:  1999-04       Impact factor: 4.982

2.  The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease.

Authors:  J Charrow; H C Andersson; P Kaplan; E H Kolodny; P Mistry; G Pastores; B E Rosenbloom; C R Scott; R S Wappner; N J Weinreb; A Zimran
Journal:  Arch Intern Med       Date:  2000-10-09

3.  The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis.

Authors:  Paige Kaplan; Hans C Andersson; Katherine A Kacena; John D Yee
Journal:  Arch Pediatr Adolesc Med       Date:  2006-06

4.  Gaucher disease--Norrbottnian type. I. General clinical description.

Authors:  S Dreborg; A Erikson; B Hagberg
Journal:  Eur J Pediatr       Date:  1980-03       Impact factor: 3.183

5.  Enzyme replacement therapy and bony changes in Egyptian paediatric Gaucher disease patients.

Authors:  A El-Beshlawy; L Ragab; I Youssry; K Yakout; H El-Kiki; K Eid; I M Mansour; S Abd El-Hamid; M Yang; P K Mistry
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

6.  Clinical and genetic studies of Japanese homozygotes for the Gaucher disease L444P mutation.

Authors:  H Ida; O M Rennert; K Iwasawa; M Kobayashi; Y Eto
Journal:  Hum Genet       Date:  1999 Jul-Aug       Impact factor: 4.132

Review 7.  A severity scoring tool to assess the neurological features of neuronopathic Gaucher disease.

Authors:  E H Davies; R Surtees; C DeVile; I Schoon; A Vellodi
Journal:  J Inherit Metab Dis       Date:  2007-09-16       Impact factor: 4.982

8.  Clinical and molecular characteristics of Japanese Gaucher disease.

Authors:  Y Eto; H Ida
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

9.  Gaucher disease--Norrbottnian type (III). Neuropaediatric and neurobiological aspects of clinical patterns and treatment.

Authors:  A Erikson
Journal:  Acta Paediatr Scand Suppl       Date:  1986

10.  Characterization of neuronopathic Gaucher disease among ethnic Poles.

Authors:  Anna Tylki-Szymañska; Mehdi Keddache; Gregory A Grabowski
Journal:  Genet Med       Date:  2006-01       Impact factor: 8.822

View more
  33 in total

Review 1.  Revised recommendations for the management of Gaucher disease in children.

Authors:  Paige Kaplan; Hagit Baris; Linda De Meirleir; Maja Di Rocco; Amal El-Beshlawy; Martina Huemer; Ana Maria Martins; Ioana Nascu; Marianne Rohrbach; Lynne Steinbach; Ian J Cohen
Journal:  Eur J Pediatr       Date:  2012-07-08       Impact factor: 3.183

2.  Four-year follow-up of chronic neuronopathic Gaucher disease in Europeans using a modified severity scoring tool.

Authors:  Elin Haf Davies; Eugen Mengel; Anna Tylki-Szymanska; G Kleinotiene; Joerg Reinke; Ashok Vellodi
Journal:  J Inherit Metab Dis       Date:  2011-05-28       Impact factor: 4.982

Review 3.  The clinical management of Type 2 Gaucher disease.

Authors:  Karin Weiss; Ashley Gonzalez; Grisel Lopez; Leah Pedoeim; Catherine Groden; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2014-11-14       Impact factor: 4.797

4.  Jaw bones' involvement and dental features of type I and type III Gaucher disease: a radiographic study of 42 paediatric patients.

Authors:  Y S A Mohamed; M K Zayet; O M Omar; A M El-Beshlawy
Journal:  Eur Arch Paediatr Dent       Date:  2019-09-17

Review 5.  Gaucher disease.

Authors:  Aabha Nagral
Journal:  J Clin Exp Hepatol       Date:  2014-04-21

Review 6.  Neuropathic Gaucher disease.

Authors:  Gregory M Pastores
Journal:  Wien Med Wochenschr       Date:  2010-12

Review 7.  Gaucher disease: Progress and ongoing challenges.

Authors:  Pramod K Mistry; Grisel Lopez; Raphael Schiffmann; Norman W Barton; Neal J Weinreb; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2016-11-17       Impact factor: 4.797

8.  Evoked potentials and neurocognitive functions in pediatric Egyptian Gaucher patients on enzyme replacement therapy: a single center experience.

Authors:  Azza Abdel Gawad Tantawy; Eman Mounir Sherif; Amira Abdel Moneam Adly; Sahar Hassanine; Amina Hafez Awad
Journal:  J Inherit Metab Dis       Date:  2013-03-19       Impact factor: 4.982

9.  Lysosomal Storage Disorders in Egyptian Children.

Authors:  Mohamed A Elmonem; Iman G Mahmoud; Dina A Mehaney; Sahar A Sharaf; Sawsan A Hassan; Azza Orabi; Fadia Salem; Marian Y Girgis; Amira El-Badawy; Magy Abdelwahab; Zeinab Salah; Neveen A Soliman; Fayza A Hassan; Laila A Selim
Journal:  Indian J Pediatr       Date:  2016-02-02       Impact factor: 1.967

10.  Pharmacotherapy of Gaucher Disease: Current and Future Options.

Authors:  Lunawati L Bennett; Chris Fellner
Journal:  P T       Date:  2018-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.